Ionis Pharmaceutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ionis Pharmaceutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ionis Pharmaceutics Today - Breaking & Trending Today

Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND Filing

Published: September 20, 2022

/PRNewswire/ -- Invitae (NYSE: NVTA) and Praxis Precision Medicines, Inc. (NASDAQ: PRAX), today announced that real-world clinical insights from Invitae's...

Source: prnewswire.com

Related Topics:

United StatesAlexandra BerkInvitae CiitizenSteven PetrouRobert NussbaumAlex KaneAmy HadsockPrnewswire InvitaeDrug AdministrationExchange CommissionInvitae CorporationIonis Pharmaceutics IncRogcon IncPraxis Precision Medicines IncEuropean Medicines AgencyPraxis Precision MedicinesPraxi Investigational New DrugOrphan Drug DesignationRare Pediatric Disease DesignationIonis PharmaceuticsPrecision MedicinesPrivate Securities Litigation Reform ActQuarterly ReportAlthough PraxiPrecision Medicines Contact